SCHEMBL418192

SCHEMBL418192

CCCCc1nnc(-c2ccc(C(C)(C)C)cc2)[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
TP53 P04637 1/20 0.39
TSHR P16473 1/20 0.39
ADORA3 P0DMS8 2/20 0.38
TNKS O95271 2/20 0.38
TNKS2 Q9H2K2 2/20 0.38
PARP1 P09874 1/20 0.37
XDH P47989 1/20 0.37
KIF11 P52732 1/20 0.37
GNRHR P30968 1/20 0.37
RARB P10826 1/20 0.37
NPBWR1 P48145 1/20 0.36
TRPV1 Q8NER1 1/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL418535 0.90 HDAC6 (0.43) HDAC6SMN1; SMN2NPC1RAB9ATP53
SCHEMBL415070 0.83 HDAC6 (0.45) HDAC6SMN1; SMN2NPC1RAB9ATP53
SCHEMBL17978577 0.81 SMN1; SMN2 (0.44) SMN1; SMN2NPC1RAB9ATP53TSHR
SCHEMBL419228 0.79 HDAC6 (0.44) HDAC6SMN1; SMN2NPC1RAB9ATNKS
SCHEMBL17978470 0.75 NPBWR1 (0.49) SMN1; SMN2NPC1RAB9AXDHNPBWR1
SCHEMBL415167 0.74 HDAC6 (0.47) HDAC6SMN1; SMN2NPC1RAB9ATP53
SCHEMBL417384 0.73 HDAC6 (0.47) HDAC6SMN1; SMN2NPC1RAB9ATP53
SCHEMBL416514 0.73 HDAC6 (0.56) HDAC6NPC1RAB9ATNKSTNKS2
SCHEMBL414390 0.73 HDAC6 (0.47) HDAC6SMN1; SMN2NPC1RAB9ATP53
SCHEMBL421297 0.71 KIF11 (0.68) HDAC6NPC1RAB9ATP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120022083-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2012-01-26 US claimed
US-20090291967-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2009-11-26 US claimed
US-20120022083-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2012-01-26 US disclosed
US-20120022083-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2012-01-26 US disclosed
US-20120022083-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2012-01-26 US disclosed
US-20090291967-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2009-11-26 US disclosed
US-20090291967-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2009-11-26 US disclosed
US-20090291967-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291967-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION CDH1, EPCAM, ICAM1 HDAC6 767/4885SMN1; SMN2 4029/4885NPC1 3435/4885
US-20120022083-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION CDH1, EPCAM, ICAM1 HDAC6 767/4885SMN1; SMN2 4029/4885NPC1 3435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.